Texas 2025 - 89th Regular

Texas House Bill HB3399 Latest Draft

Bill / Introduced Version Filed 02/26/2025

Download
.pdf .doc .html
                            89R8311 EAS-D
 By: Money H.B. No. 3399




 A BILL TO BE ENTITLED
 AN ACT
 relating to the provision of procedures and treatments for gender
 transitioning, gender reassignment, or gender dysphoria and the use
 of public money or public assistance to provide those procedures or
 treatments.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  The heading to Subchapter X, Chapter 161, Health
 and Safety Code, as added by Chapter 335 (S.B. 14), Acts of the 88th
 Legislature, Regular Session, 2023, is amended to read as follows:
 SUBCHAPTER X. GENDER TRANSITIONING AND GENDER REASSIGNMENT
 PROCEDURES AND TREATMENTS [FOR CERTAIN CHILDREN]
 SECTION 2.  Sections 161.701, 161.702, 161.703, 161.704, and
 161.705, Health and Safety Code, as added by Chapter 335 (S.B. 14),
 Acts of the 88th Legislature, Regular Session, 2023, are amended to
 read as follows:
 Sec. 161.701.  DEFINITIONS.  In this subchapter:
 (1)  ["Child" means an individual who is younger than
 18 years of age.
 [(2)]  "Health care provider" means a person other than
 a physician who is licensed, certified, or otherwise authorized by
 this state's laws to provide or render health care or to dispense or
 prescribe a prescription drug in the ordinary course of business or
 practice of a profession.
 (2) [(3)]  "Medicaid" means the medical assistance
 program established under Chapter 32, Human Resources Code.
 (3) [(4)]  "Physician" means a person licensed to
 practice medicine in this state.
 Sec. 161.702.  PROHIBITED PROVISION OF GENDER TRANSITIONING
 OR GENDER REASSIGNMENT PROCEDURES AND TREATMENTS [TO CERTAIN
 CHILDREN].  For the purpose of transitioning a person's [child's]
 biological sex as determined by the sex organs, chromosomes, and
 endogenous profiles of the person [child] or affirming the person's
 [child's] perception of the person's [child's] sex if that
 perception is inconsistent with the person's [child's] biological
 sex, a physician or health care provider may not knowingly:
 (1)  perform a surgery that sterilizes the person
 [child], including:
 (A)  castration;
 (B)  vasectomy;
 (C)  hysterectomy;
 (D)  oophorectomy;
 (E)  metoidioplasty;
 (F)  orchiectomy;
 (G)  penectomy;
 (H)  phalloplasty; and
 (I)  vaginoplasty;
 (2)  perform a mastectomy;
 (3)  provide, prescribe, administer, or dispense any of
 the following prescription drugs that induce transient or permanent
 infertility:
 (A)  puberty suppression or blocking prescription
 drugs to stop or delay normal puberty;
 (B)  supraphysiologic doses of testosterone to
 females; or
 (C)  supraphysiologic doses of estrogen to males;
 or
 (4)  remove any otherwise healthy or non-diseased body
 part or tissue.
 Sec. 161.703.  EXCEPTIONS.  (a)  Section 161.702 does not
 apply to the provision by a physician or health care provider to a
 person, including a child with the consent of the child's parent or
 legal guardian, of:
 (1)  puberty suppression or blocking prescription
 drugs for the purpose of normalizing puberty for a minor
 experiencing precocious puberty; or
 (2)  appropriate and medically necessary procedures or
 treatments to a person [child] who:
 (A)  is born with a medically verifiable genetic
 disorder of sex development, including:
 (i)  46,XX chromosomes with virilization;
 (ii)  46,XY chromosomes with
 undervirilization; or
 (iii)  both ovarian and testicular tissue;
 or
 (B)  does not have the normal sex chromosome
 structure for male or female as determined by a physician through
 genetic testing.
 (b)  Section 161.702 does not apply to the provision of a
 prescription drug to a person [child] that is otherwise prohibited
 by that section if:
 (1)  the prescription drug is part of a continuing
 course of treatment that the person [child] began before June 1,
 2025 [2023]; and
 (2)  the person [child] attended 12 or more sessions of
 mental health counseling or psychotherapy during a period of at
 least six months before the date the course of treatment described
 by Subdivision (1) began.
 (c)  A person [child] to whom the exception under Subsection
 (b) applies:
 (1)  shall wean off the prescription drug over a period
 of time and in a manner that is safe and medically appropriate and
 that minimizes the risk of complications; and
 (2)  may not switch to or begin a course of treatment on
 another prescription drug that a physician or health care provider
 is prohibited from providing to the person [child] under Section
 161.702 or otherwise receive a procedure or treatment prohibited by
 that section.
 Sec. 161.704.  PROHIBITED USE OF PUBLIC MONEY.  Public money
 may not directly or indirectly be used, granted, paid, or
 distributed to any health care provider, medical school, hospital,
 physician, or any other entity, organization, or individual that
 provides or facilitates the provision of a procedure or treatment
 to a person [child] that is prohibited under Section 161.702.
 Sec. 161.705.  PROHIBITED STATE HEALTH PLAN REIMBURSEMENT.
 The commission may not provide Medicaid reimbursement and the child
 health plan program established by Chapter 62 may not provide
 reimbursement to a physician or health care provider for provision
 of a procedure or treatment to a person [child] that is prohibited
 under Section 161.702.
 SECTION 3.  Section 32.024(pp), Human Resources Code, as
 added by Chapter 335 (S.B. 14), Acts of the 88th Legislature,
 Regular Session, 2023, is redesignated as Section 32.024(rr), Human
 Resources Code, and amended to read as follows:
 (rr) [(pp)]  The medical assistance program may not provide
 coverage for services prohibited by Section 161.702, Health and
 Safety Code, that are intended to transition a person's [child's]
 biological sex as determined by the person's [child's] sex organs,
 chromosomes, and endogenous profiles.
 SECTION 4.  The heading to Section 164.0552, Occupations
 Code, is amended to read as follows:
 Sec. 164.0552.  PROHIBITED ACTS REGARDING GENDER
 TRANSITIONING OR GENDER REASSIGNMENT PROCEDURES AND TREATMENTS [ON
 CERTAIN CHILDREN].
 SECTION 5.  If before implementing any provision of this Act
 a state agency determines a waiver or authorization from a federal
 agency is necessary for implementation of that provision, the
 agency affected by the provision shall request the waiver or
 authorization and may delay implementing that provision until the
 waiver or authorization is granted.
 SECTION 6.  This Act takes effect September 1, 2025.